5Tuomisto K,Jousilahti P,Sundvall J,et al.C-reactive protein,interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality[J].Thromb Haemost,2006,95(3):511-518. 被引量：1
6Dichtl W,Dulak J,Frick M,et al.HMG-CoA reductase inhibitors regulate inflammatorv transcription factors in human endothelial and vascular smooth muscle cells[J].Arterioscler Thmmb Vasc Biol,2003,23(1):58-63. 被引量：1
7Landmesser U,Bahlmann F,Mueller M,et al.Simvastatin versus ezetimibe:pleiotropic and lipid-lowering effects on endothelial function in humans[J].Circulation,2005,111(18):2356-2363. 被引量：1
8Yamamoto A, Hoshi K, Ichihara K. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes.Eur J Pharmacol 1998; 361:143-149. 被引量：1
9Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P,Smethurst P, Delacey G, Gumpel MJ, Levi AJ. Nonsteroidal anti-inflammatory drug-induced intestinal inflammation inhumans. Gastroenterology 1987; 93:480-489. 被引量：1
10Langman MJ. Epidemiologic evidence on the assocation between peptic ulceration and antiinflammatory drug use. Gastroenterology 1989; 96:640-646. 被引量：1
